# 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

> **NCT06048094** · PHASE1 · RECRUITING · sponsor: **Baptist Health South Florida** · enrollment: 46 (estimated)

## Conditions studied

- Brain Metastases
- Brain Metastases, Adult
- Brain Cancer

## Interventions

- **DRUG:** 18F fluciclovine

## Key facts

- **NCT ID:** NCT06048094
- **Lead sponsor:** Baptist Health South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-11
- **Primary completion:** 2026-05
- **Final completion:** 2027-05
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06048094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06048094, "18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06048094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*